These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. Janssen MJ, Salomon J, Te Morsche RH, Drenth JP. PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713 [Abstract] [Full Text] [Related]
5. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene. Cnossen WR, Maurits JS, Salomon J, Te Morsche RH, Waanders E, Drenth JP. J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003 [Abstract] [Full Text] [Related]
6. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Waanders E, te Morsche RH, de Man RA, Jansen JB, Drenth JP. Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903 [Abstract] [Full Text] [Related]
7. Isolated polycystic liver disease genes define effectors of polycystin-1 function. Besse W, Dong K, Choi J, Punia S, Fedeles SV, Choi M, Gallagher AR, Huang EB, Gulati A, Knight J, Mane S, Tahvanainen E, Tahvanainen P, Sanna-Cherchi S, Lifton RP, Watnick T, Pei YP, Torres VE, Somlo S. J Clin Invest; 2017 May 01; 127(5):1772-1785. PubMed ID: 28375157 [Abstract] [Full Text] [Related]